EXHIBIT 10.6 *CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS LICENSE AGREEMENT Effective as of July 1, 1999 ("Effective...License Agreement • February 10th, 2004 • Corcept Therapeutics Inc • Pharmaceutical preparations • California
EXHIBIT 10.5 INDEMNIFICATION AGREEMENT AGREEMENT, made this ____ day of ___________, 200__, between Corcept Therapeutics Incorporated, a Delaware corporation (the "Company"), and ____________ (the "Indemnitee"). W I T N E S S E T H: - - - - - - - - -...Indemnification Agreement • February 10th, 2004 • Corcept Therapeutics Inc • Pharmaceutical preparations • Delaware
EXHIBIT 10.9 *CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS Memorandum of Understanding Supply and Services Agreement for...Memorandum of Understanding • February 10th, 2004 • Corcept Therapeutics Inc • Pharmaceutical preparations
Consultant accepts engagement by the Company as a consultant beginning on the Effective Date and continuing until May , 2000, which one-year term will -- be automatically extended for additional one-year periods unless terminated by either party by...Consulting Agreement • February 10th, 2004 • Corcept Therapeutics Inc • Pharmaceutical preparations • California
EXHIBIT 4.2 CORCEPT THERAPEUTICS INCORPORATED AMENDED AND RESTATED INFORMATION AND REGISTRATION RIGHTS AGREEMENTInformation and Registration Rights Agreement • February 10th, 2004 • Corcept Therapeutics Inc • Pharmaceutical preparations • California
CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS RESEARCH AGREEMENT/ cGMP MANUFACTURINGResearch Agreement • February 10th, 2004 • Corcept Therapeutics Inc • Pharmaceutical preparations • Delaware
This agreement is entered into by and between **** hereinafter called “Research Organization”, and Corcept Therapeutics Incorporated a corporation with its principal office and place of business at 275 Middlefield Road, Suite A, Menlo Park, CA 94025, hereinafter called “Sponsor”.
MASTERMaster Clinical Development Agreement • February 10th, 2004 • Corcept Therapeutics Inc • Pharmaceutical preparations • California
